Pearson R D, Symes P, Conboy M, Weiss A A, Hewlett E L
Division of Geographic Medicine, University of Virginia School of Medicine, Charlottesville 22908.
J Immunol. 1987 Oct 15;139(8):2749-54.
Bordetella pertussis and the other Bordetella species produce a novel adenylate cyclase toxin which enters target cells to catalyze the production of supraphysiologic levels of intracellular cyclic adenosine monophosphate (cAMP). In these studies, dialyzed extracts from B. pertussis containing the adenylate cyclase toxin, a partially purified preparation of adenylate cyclase toxin, and extracts from transposon Tn5 mutants of B. pertussis lacking the adenylate cyclase toxin, were used to assess the effects of adenylate cyclase toxin on human peripheral blood monocyte activities. Luminol-enhanced chemiluminescence of monocytes stimulated with opsonized zymosan was inhibited greater than 96% by exposure to adenylate cyclase toxin-containing extract, but not by extracts from adenylate cyclase toxin-deficient mutants. The chemiluminescence responses to particulate (opsonized zymosan, Leishmania donovani, and Staphylococcus aureus) and soluble (phorbol myristate acetate) stimuli were inhibited equivalently. The superoxide anion generation elicited by opsonized zymosan was inhibited 92% whereas that produced by phorbol myristate acetate was inhibited only 32% by B. pertussis extract. Inhibition of oxidative activity was associated with a greater than 500-fold increase in monocyte cAMP levels, but treated monocytes remained viable as assessed by their ability to exclude trypan blue and continued to ingest particulate stimuli. The major role of the adenylate cyclase toxin in the inhibition of monocyte oxidative responses was demonstrated by: 1) little or no inhibition by extracts from B. pertussis mutants lacking adenylate cyclase toxin; 2) high level inhibition with extract from B. parapertussis, a related species lacking pertussis toxin; and 3) a reciprocal relationship between monocyte cAMP levels and inhibition of opsonized zymosan-induced chemiluminescence using both crude extract and partially purified adenylate cyclase toxin. Pertussis toxin, which has been shown to inhibit phagocyte responses to some stimuli by a cAMP-independent mechanism, had only a small (less than 20%) inhibitory effect when added at concentrations up to 100-fold in excess of those present in B. pertussis extract. These data provide strong support for the hypothesis that B. pertussis adenylate cyclase toxin can increase cAMP levels in monocytes without compromising target cell viability or impairing ingestion of particles and that the resultant accumulated cAMP is responsible for the inhibition of oxidative responses to a variety of stimuli.
百日咳博德特氏菌及其他博德特氏菌属细菌可产生一种新型腺苷酸环化酶毒素,该毒素进入靶细胞后催化产生超生理水平的细胞内环状腺苷单磷酸(cAMP)。在这些研究中,使用了含有腺苷酸环化酶毒素的百日咳博德特氏菌透析提取物、腺苷酸环化酶毒素的部分纯化制剂,以及缺乏腺苷酸环化酶毒素的百日咳博德特氏菌转座子Tn5突变体的提取物,来评估腺苷酸环化酶毒素对人外周血单核细胞活性的影响。用调理酵母聚糖刺激的单核细胞的鲁米诺增强化学发光,在暴露于含腺苷酸环化酶毒素的提取物后受到大于96%的抑制,但在暴露于腺苷酸环化酶毒素缺陷突变体的提取物后未受抑制。对颗粒性(调理酵母聚糖、杜氏利什曼原虫和金黄色葡萄球菌)和可溶性(佛波酯肉豆蔻酸酯)刺激的化学发光反应受到同等程度的抑制。调理酵母聚糖引发的超氧阴离子生成被百日咳博德特氏菌提取物抑制了92%,而佛波酯肉豆蔻酸酯引发的超氧阴离子生成仅被抑制了32%。氧化活性的抑制与单核细胞cAMP水平增加500倍以上相关,但经处理的单核细胞通过排斥台盼蓝的能力评估仍保持存活,并继续摄取颗粒性刺激物。腺苷酸环化酶毒素在抑制单核细胞氧化反应中的主要作用通过以下几点得以证明:1)缺乏腺苷酸环化酶毒素的百日咳博德特氏菌突变体的提取物几乎没有抑制作用;2)缺乏百日咳毒素的相关物种副百日咳博德特氏菌的提取物具有高水平抑制作用;3)使用粗提物和部分纯化的腺苷酸环化酶毒素时,单核细胞cAMP水平与调理酵母聚糖诱导的化学发光抑制之间存在反比关系。已证明百日咳毒素通过一种不依赖cAMP的机制抑制吞噬细胞对某些刺激的反应,当以比百日咳博德特氏菌提取物中浓度高100倍的浓度添加时,其抑制作用仅为很小(小于20%)。这些数据为以下假说提供了有力支持:百日咳博德特氏菌腺苷酸环化酶毒素可增加单核细胞中的cAMP水平,而不损害靶细胞活力或损害颗粒摄取,并且由此积累的cAMP负责抑制对多种刺激的氧化反应。